Invesaro

Stocks Comparison

Davita vs Sotera Health: revenue, profit, margins and growth compared

Davita brought in $13.6B of revenue in fiscal 2025, Sotera Health $1.2B in fiscal 2025. Revenue changed by +6.5% at Davita and +5.7% at Sotera Health on the year before, so Davita grew faster. Davita kept 5.5% of its revenue as net profit, Sotera Health 6.7%. Free cash flow was $1.3B at Davita and $149.2M at Sotera Health.

Side by side, latest fiscal year

DVASHC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$13.6B$1.2B
Revenue growth+6.5%+5.7%
Net income$746.8M$77.9M
Net margin5.5%6.7%
Free cash flow$1.3B$149.2M
Free cash flow margin9.6%12.8%
Earnings per share (diluted)$9.84$0.27
Cash$676.4M$344.6M
Debt$10.3B$2.1B
Price to earnings18.167.9
Market value$11.4B$5.2B
Dividend yieldn/an/a
Rank by revenue in sector#36 of 523 · Health care#138 of 523 · Health care

Over the years

Revenue
DVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BSHC FY2019: $778.3MSHC FY2021: $818.2MSHC FY2021: $931.5MSHC FY2022: $1BSHC FY2023: $1BSHC FY2024: $1.1BSHC FY2025: $1.2BFY18FY19FY20FY21FY22FY23FY24FY25
DVA $13.6BSHC $1.2B
Net income
DVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MSHC FY2019: -$20.9MSHC FY2021: -$38.6MSHC FY2021: $116.9MSHC FY2022: -$233.6MSHC FY2023: $51.4MSHC FY2024: $44.4MSHC FY2025: $77.9MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $746.8MSHC $77.9M
Net margin
DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%SHC FY2019: -2.7%SHC FY2021: -4.7%SHC FY2021: 12.5%SHC FY2022: -23.3%SHC FY2023: 4.9%SHC FY2024: 4.0%SHC FY2025: 6.7%FY18FY19FY20FY21FY22FY23FY24FY25
DVA 5.5%SHC 6.7%
Revenue growth
DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%SHC FY2021: +5.1%SHC FY2021: +13.9%SHC FY2022: +7.8%SHC FY2023: +4.5%SHC FY2024: +4.9%SHC FY2025: +5.7%FY19FY20FY21FY22FY23FY24FY25
DVA +6.5%SHC +5.7%
Free cash flow
DVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BSHC FY2019: $91.8MSHC FY2021: $67.1MSHC FY2021: $179.4MSHC FY2022: $95.6MSHC FY2023: -$362.7MSHC FY2024: $45.1MSHC FY2025: $149.2MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $1.3BSHC $149.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Davita and Sotera Health

Which is bigger by revenue, Davita or Sotera Health?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $1.2B for Sotera Health in fiscal 2025.

Which keeps more of its revenue as profit, Davita or Sotera Health?

Davita had a net margin of 5.5% in fiscal 2025; Sotera Health had 6.7% in fiscal 2025.

Which grew revenue faster, Davita or Sotera Health?

In their latest fiscal years revenue changed by +6.5% at Davita and +5.7% at Sotera Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies